Clinical and epidemiological observations on individual radiation sensitivity and susceptibility

References

• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes J. C J M D. 1993. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 85(5):365–376.
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Alsner J. 2009. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol. 92(3):299–309.
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, International Radiogenomics Consortium (RgC). 2016. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiother Oncol. 121(3):431–439.
   PubMed Web of Science ®Google Scholar
• Asdahl PH, Winther JF, Bonnesen TG, De Fine Licht S, Gudmundsdottir T, Anderson H, Madanat-Harjuoja L, Tryggvadottir L, Småstuen MC, Holmqvist AS, et al. 2015. The Adult Life after Childhood Cancer in Scandinavia (ALiCCS) Study: design and characteristics. Pediatr Blood Cancer. 62(12):2204–2210.
   PubMed Web of Science ®Google Scholar
• Averbeck D, Salomaa S, Bouffler S, Ottolenghi A, Smyth V, Sabatier L. 2018. Progress in low dose health risk research. Novel effects and new concepts in low dose radiobiology. Mut Res Rev Mut Res. 776:46–69.
   PubMed Web of Science ®Google Scholar
• Averbeck D, Candéias S, Chandna S, Foray N, Friedl A, Haghdoost S, Jeggo PA, Lumniczky K, Paris F, Sabatier L, et al. 2019. Establishing the mechanisms affecting the individual response to ionising radiation. Int J Radiat Biol [in this issue].
   PubMed Web of Science ®Google Scholar
• Azizova TV, Hamada N, Grigoryeva ES, Bragin EV. 2018. Risk of various types of cataracts in a cohort of Mayak workers following chronic occupational exposure to ionizing radiation. Eur J Epidemiol. 33(12):1193–1204.
   PubMed Web of Science ®Google Scholar
• Aznar MC, Girinsky T, Berthelsen AK, Aleman B, Beijert M, Hutchings M, Lievens Y, Meijnders P, Meidahl Petersen P, Schut D, et al. 2017. Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group. Acta Oncol. 56(4):608–613.
   PubMed Web of Science ®Google Scholar
• Azria D, Riou O, Castan F, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, et al. 2015. Radiation-induced CD8 T-lymphocyte apoptosis as a predictor of breast fibrosis after radiotherapy: results of the prospective multicenter French trial. EBioMedicine. 2(12):1965–1973.
   PubMed Web of Science ®Google Scholar
• Barnett GC, West CM, Coles CE, Pharoah PD, Talbot CJ, Elliott RM, Tanteles GA, Symonds RP, Wilkinson JS, Dunning AM, et al. 2012. Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies. Int J Radiat Oncol Biol Phys. 82(3):1065–1074.
   PubMed Web of Science ®Google Scholar
• Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, Burnet NG. 2009. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer. 9(2):134–142.
   PubMed Web of Science ®Google Scholar
• Beauchamp TL, Childress JF. 2013. Principles of biomedical ethics. 7th ed. Oxford, UK: Oxford University Press.
   Google Scholar
• Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, et al. 1996. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 276(8):637–639.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, Ten Haken RK, Yorke ED. 2010. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 76(3):S3–S9.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Overgaard J. 1994. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol. 4(2):68–80.
   PubMedGoogle Scholar
• Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E. 2011. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol. 12(4):353–360.
   PubMed Web of Science ®Google Scholar
• Berrington de Gonzalez A, Gilbert E, Curtis R, Inskip P, Kleinerman R, Morton L, Rajaraman P, Little MP. 2013. Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship. Int J Radiat Oncol Biol Phys. 86(2):224–233.
   PubMed Web of Science ®Google Scholar
• Bhatti P, Doody MM, Rajaraman P, Alexander BH, Yeager M, Hutchinson A, Burdette L, Thomas G, Hunter DJ, Simon SL, et al. 2010. Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. radiologic technologists. Radiat Res. 173(2):214–224.
   PubMed Web of Science ®Google Scholar
• Bonassi S, Norppa H, Ceppi M, Strömberg U, Vermeulen R, Znaor A, Cebulska-Wasilewska A, Fabianova E, Fucic A, Gundy S, et al. 2008. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis. 29(6):1178–1183.
   PubMed Web of Science ®Google Scholar
• Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, et al. 2006. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis. 28(3):625–631.
   PubMed Web of Science ®Google Scholar
• Brandl A, Tschurlovits M. 2018. Professional ethics in radiological protection. J Radiol Prot. 38(4):1524–1534.
   PubMed Web of Science ®Google Scholar
• Bräuner EV, Andersen CE, Sørensen M, Andersen ZJ, Gravesen P, Ulbak K, Hertel O, Pedersen C, Overvad K, Tjønneland A, Raaschou-Nielsen O. 2012. Residential radon and lung cancer incidence in a Danish cohort. Environ Res. 118:130–136.
   PubMed Web of Science ®Google Scholar
• Bräuner EV, Andersen CE, Andersen HP, Gravesen P, Lind M, Ulbak K, Hertel O, Schüz J, Raaschou-Nielsen O. 2010. Is there any interaction between domestic radon exposure and air pollution from traffic in relation to childhood leukemia risk? Cancer Causes Control. 21(11):1961–1964.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, Lubin JH, Preston DL, Preston RJ, Puskin JS, et al. 2003. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA. 100(24):13761–13766.
   PubMed Web of Science ®Google Scholar
• Cahoon EK, Preston DL, Pierce DA, Grant E, Brenner AV, Mabuchi K, Utada M, Ozasa K. 2017. Lung, laryngeal and other respiratory cancer incidence among Japanese atomic bomb survivors: an updated analysis from 1958 through 2009. Radiat Res. 187(5):538–548.
   PubMed Web of Science ®Google Scholar
• Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, et al. 2005. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst. 97(10):724–732.
   PubMedGoogle Scholar
• Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, et al. 1993. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 11(3):570–579.
   PubMed Web of Science ®Google Scholar
• Chaikh A, Calugaru V, Bondiau PY, Thariat J, Balosso J. 2018. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans. Int J Radiat Biol. 94(9):789–797.
   PubMed Web of Science ®Google Scholar
• Cho KW, Cantone MC, Kurihara-Saio C, Le Guen B, Martinez N, Oughton D, Schneider T, Toohey R, ZöLzer F, Authors on behalf of ICRP. 2018. ICRP Publication 138: ethical foundations of the system of radiological protection. Ann ICRP. 47(1):1–65.
   PubMedGoogle Scholar
• Chodick G, Bekiroglu N, Hauptmann M, Alexander BH, Freedman DM, Doody MM, Cheung LC, Simon SL, Weinstock RM, Bouville A, et al. 2008. Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists. Am J Epidemiol. 168(6):620–631.
   PubMed Web of Science ®Google Scholar
• Chylack LT, Jr, Peterson LE, Feiveson AH, Wear ML, Manuel FK, Tung WH, Hardy DS, Marak LJ, Cucinotta FA, NASA study of cataract in astronauts (NASCA) 2009. Report 1: cross-sectional study of the relationship of exposure to space radiation and risk of lens opacity. Radiat Res. 172(1):10–20.
   PubMed Web of Science ®Google Scholar
• Colin C, Foray N, Di Leo G, Sardanelli F. 2017. Radiation induced breast cancer risk in BRCA mutation carriers from low-dose radiological exposures: a systematic review. Radioprotection. 52(4):231–240.
   Web of Science ®Google Scholar
• Cowley L. 2016. What can we Learn from patients' ethical thinking about the right 'not to know' in genomics? Lessons from Cancer Genetic Testing for Genetic Counselling. Bioethics. 30(8):628–635.
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. 1995. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31(5):1341–1346.
   PubMed Web of Science ®Google Scholar
• Cucinotta FA, Chappell LJ, Kim MH, Wang M. 2012. Radiation carcinogenesis risk assessments for never-smokers. Health Phys. 103(5):643–651.
   PubMed Web of Science ®Google Scholar
• Cucinotta FA, Manuel FK, Jones J, Iszard G, Murrey J, Djojonegro B, Wear M. 2001. Space radiation and cataracts in astronauts. Radiat Res. 156(5 Pt 1):460–466.
   PubMed Web of Science ®Google Scholar
• Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ, et al. 2010. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys. 76(3):656–665.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, et al. 2013. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 368(11):987–998.
   PubMed Web of Science ®Google Scholar
• Darby S, Hill D, Deo H, Auvinen A, Barros-Dios JM, Baysson H, Bochicchio F, Falk R, Farchi S, Figueiras A, et al. 2006. Residential radon and lung cancer–detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand J Work Environ Health. 32(1):1–83.
   PubMed Web of Science ®Google Scholar
• Dracham CB, Shankar A, Madan R. 2018. Radiation induced secondary malignancies: a review article. Radiat Oncol J. 36(2):85–94.
   PubMed Web of Science ®Google Scholar
• Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, et al. 2015. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 1(8):1051–1059.
   PubMed Web of Science ®Google Scholar
• Einstein AJ. 2012. Beyond the bombs: cancer risks of low-dose medical radiation. Lancet. 380(9840):455–457.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, Cola L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. 1991. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21(1):109–122.
   PubMed Web of Science ®Google Scholar
• Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. 1997. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 50(6):920–928.
   PubMed Web of Science ®Google Scholar
• Fachal L, Gómez-Caamaño A, Barnett GC, Peleteiro P, Carballo AM, Calvo-Crespo P, Kerns SL, Sánchez-García M, Lobato-Busto R, Dorling L, et al. 2014. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nat Genet. 46(8):891–894.
   PubMed Web of Science ®Google Scholar
• Fisher DR, Fahey FH. 2017. Appropriate use of effective dose in radiation protection and risk assessment. Health Phys. 113(2):102–109.
   PubMed Web of Science ®Google Scholar
• Foray N, Bourguignon M, Hamada N. 2016. Individual response to ionizing radiation. Mutat Res. 770:369–386.
   PubMed Web of Science ®Google Scholar
• Foray N, Colin C, Bourguignon M. 2012. 100 years of individual radiosensitivity: how we have forgotten the evidence. Radiology. 264(3):627–631.
   PubMed Web of Science ®Google Scholar
• Frieben A. 1902. Cancroid des rechten Handrückens. Dtsch Med Wschr. 28:335.
   Google Scholar
• Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP. 2010. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 102(14):1083–1095.
   PubMedGoogle Scholar
• Gilbert ES, Sokolnikov ME, Preston DL, Schonfeld SJ, Schadilov AE, Vasilenko EK, Koshurnikova NA. 2013. Lung cancer risks from plutonium: an updated analysis of data from the Mayak worker cohort. Radiat Res. 179(3):332–342.
   PubMed Web of Science ®Google Scholar
• Gomolka M, Blyth B, Bourguignon M, Badie C, Schmitz A, Talbot C, Hoeschen C, Salomaa S. 2019. Potential screening assays for individual radiation sensitivity and susceptibility and their current validation state. Int J Radiat Biol. 95:1–17.
   PubMedGoogle Scholar
• Grabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Bright CJ, et al. 2018. The PanCareSurfUp cohort of 83,333 five-year survivors of childhood cancer: a cohort study from 12 European countries. Eur J Epidemiol. 33(3):335–349.
   PubMed Web of Science ®Google Scholar
• Grant EJ, Brenner A, Sugiyama H, Sakata R, Sadakane A, Utada M, Cahoon EK, Milder CM, Soda M, Cullings HM, et al. 2017. Solid cancer incidence among the Life Span Study of Atomic Bomb Survivors: 1958–2009. Radiat Res. 187(5):513–537.
   PubMed Web of Science ®Google Scholar
• Grant EJ, Ozasa K, Preston DL, Suyama A, Shimizu Y, Sakata R, Sugiyama H, Pham TM, Cologne J, Yamada M, et al. 2012. Effects of radiation and lifestyle factors on risks of urothelial carcinoma in the Life Span Study of atomic bomb survivors. Radiat Res. 178(1):86–98.
   PubMed Web of Science ®Google Scholar
• Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L, Forcheron F, Viau M, et al. 2016. Influence of nucleoshuttling of the ATM protein in the healthy tissues response to radiation therapy: toward a molecular classification of human radiosensitivity. Int J Radiat Oncol Biol Phys. 94(3):450–460.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia AJ. 2006. Radiobiology for the Radiologist. Philadelphia, USA: Lippincott Williams & Wilkins.
   Google Scholar
• Hamada N, Salomaa S, Dörr W. 2018. Toward tailoring radiation protection strategies at an individual level. Int J Radiat Biol. 94(11):951–954.
   PubMed Web of Science ®Google Scholar
• Hawkins MM, Lancashire ER, Winter DL, Frobisher C, Reulen RC, Taylor AJ, Stevens MC, Jenney M. 2008. The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 50(5):1018–1025.
   PubMed Web of Science ®Google Scholar
• Henríquez FC, Castrillón SV. 2011. A quality index for equivalent uniform dose. J Med Phys. 36(3):126–132.
   PubMedGoogle Scholar
• HLEG 2009. HLEG Report on European Low Dose Risk Research. EUR 23884. Luxembourg, UK: Office for Official Publications of the European Communities.
   Google Scholar
• Hoeller U, Tribius S, Kuhlmey A, Grader K, Fehlauer F, Alberti W. 2003. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys. 55(4):1013–1018.
   PubMed Web of Science ®Google Scholar
• HPA 2013. Human radiosensitivity. Report of the Independent Advisory Group on Ionising radiation. Chilton, Doc HPA, RCE-21 [accessed 22 July 2017]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/333058/RCE-21_v2_for_website.pdf.
   Google Scholar
• ICRP 1998. Genetic susceptibility to cancer. ICRP Publication 79. Ann ICRP. 28(1–2):1–157.
   Google Scholar
• ICRP 2007. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann ICRP 37(2–4):1–332.
   Google Scholar
• ICRP 2012. ICRP statement on tissue reactions/early and late effects of radiation in normal tissues and organs – threshold doses for tissue reactions in a radiation protection context. ICRP Publication 118. Ann ICRP 41(1-2):1–322.
   Google Scholar
• Jackson A, Marks LB, Bentzen SM, Eisbruch A, Yorke ED, Ten Haken RK, Constine LS, Deasy JO. 2010. The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys. 76(3):S155–S60.
   PubMed Web of Science ®Google Scholar
• Kalman C, Oughton D. 2019. Ethical considerations related to radiosensitivity and radiosusceptibility. Int J Radiat Biol. DOI:10.1080/09553002.2019.1665210
   PubMed Web of Science ®Google Scholar
• Kendall GM, Little MP, Wakeford R, Bunch KJ, Miles JC, Vincent TJ, Meara JR, Murphy MF. 2013. A record-based case-control study of natural background radiation and the incidence of childhood leukaemia and other cancers in Great Britain during 1980–2006. Leukemia. 27(1):3–9.
   PubMed Web of Science ®Google Scholar
• Kendall GM1, Smith TJ. 2005. Doses from radon and its decay products to children. J Radiol Prot. 25(3):241–256.
   PubMed Web of Science ®Google Scholar
• Kerns SL, de Ruysscher D, Andreassen CN, Azria D, Barnett GC, Chang-Claude J, Davidson S, Deasy JO, Dunning AM, Ostrer H, et al. 2014. STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics. Radiother Oncol. 110(1):182–188.
   PubMed Web of Science ®Google Scholar
• Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, et al. 2016. Radiogenomics Consortium. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. EBioMedicine. 10:150–163.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Linet MS, Rajaraman P, Ntowe E, Berrington de González A. 2015. A new era of low-dose radiation epidemiology. Curr Envir Health Rpt. 2(3):236–249.
   PubMedGoogle Scholar
• Klein W, Breustedt B. 2014. Analysis of the effects of inter-individual variation in the distribution of plutonium in skeleton and liver. Radiat Prot Dosimetry. 158(3):276–284.
   PubMed Web of Science ®Google Scholar
• Kreuzer M, Auvinen A, Cardis E, Durante M, Harms-Ringdahl M, Jourdain JR, Madas BG, Ottolenghi A, Pazzaglia S, Prise KM, et al. 2018a. Multidisciplinary European Low Dose Initiative (MELODI): strategic research agenda for low dose radiation risk research. Radiat Environ Biophys. 57(1):5–15.
   PubMed Web of Science ®Google Scholar
• Kreuzer M, Auvinen A, Cardis E, Hall J, Jourdain JR, Laurier D, Little MP, Peters A, Raj K, Russell NS, et al. 2015. Low-dose ionising radiation and cardiovascular diseases – strategies for molecular epidemiological studies in Europe. Mutat Res Rev Mutat Res. 764:90–100.
   PubMed Web of Science ®Google Scholar
• Kreuzer M, Sobotzki C, Schnelzer M, Fenske N. 2018b. Factors modifying the radon-related lung cancer risk at low exposures and exposure rates among german uranium miners. Radiat Res. 189(2):165–176.
   PubMed Web of Science ®Google Scholar
• Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, Klotz JB, Létourneau EG, Lynch CF, Lyon JI, et al. 2005. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology. 16(2):137–145.
   PubMed Web of Science ®Google Scholar
• Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R. 1991. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys. 21(1):137–146.
   PubMed Web of Science ®Google Scholar
• Leuraud K, Richardson DB, Cardis E, Daniels RD, Gillies M, O'Hagan JA, Hamra GB, Haylock R, Laurier D, Moissonnier M, et al. 2015. Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study. Lancet Haematol. 2(7):e276–81.
   PubMed Web of Science ®Google Scholar
• Leuraud K, Schnelzer M, Tomasek L, Hunter N, Timarche M, Grosche B, Kreuzer M, Laurier D. 2011. Radon, smoking and lung cancer risk: results of a joint analysis of three European case-control studies among uranium miners. Radiat Res. 176(3):375–387.
   PubMed Web of Science ®Google Scholar
• Liang B, Yan H, Tian Y, Chen X, Yan L, Zhang T, Zhou Z, Wang L, Dai J. 2019. Dosiomics: extracting 3D spatial features from dose distribution to predict incidence of radiation pneumonitis. Front Oncol. 9:269. eCollection 2019.
   PubMed Web of Science ®Google Scholar
• Lilla C, Ambrosone CB, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J. 2007. Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat. 106(1):143–150.
   PubMed Web of Science ®Google Scholar
• Little MP. 2001. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors. Int J Radiat Biol. 77(4):431–464.
   PubMed Web of Science ®Google Scholar
• Little MP. 2016. Radiation and circulatory disease. Mutat Res. 770(Pt B):299–318.
   PubMedGoogle Scholar
• Little MP, Azizova TV, Bazyka D, Bouffler SD, Cardis E, Chekin S, Chumak VV, Cucinotta FA, de Vathaire F, Hall P, et al. 2012. Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ Health Perspect. 120(11):1503–1511.
   PubMed Web of Science ®Google Scholar
• Little MP, Kitahara CM, Cahoon EK, Bernier MO, Velazquez-Kronen R, Doody MM, Borrego D, Miller JS, Alexander BH, Simon SL, et al. 2018. Occupational radiation exposure and risk of cataract incidence in a cohort of US radiologic technologists. Eur J Epidemiol. 33(12):1179–1191.
   PubMed Web of Science ®Google Scholar
• Lyman JT. 1985. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 8:S13–S9.
   PubMedGoogle Scholar
• Lyman JT, Wolbarst AB. 1987. Optimization of radiation therapy, III: a method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys. 13(1):103–109.
   PubMed Web of Science ®Google Scholar
• Malone J, Zölzer F. 2016. Pragmatic ethical basis for radiation protection in diagnostic radiology. BJR. 89(1059):20150713.
   Google Scholar
• Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen SM, Nam J, Deasy JO. 2010. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 76(3):S10–S19.
   PubMed Web of Science ®Google Scholar
• Marsh JW, Harrison JD, Laurier D, Birchall A, Blanchardon E, Paquet F, Tirmarche M. 2014. Doses and lung cancer risks from exposure to radon and plutonium. Int J Radiat Biol. 90(11):1080–1087.
   PubMed Web of Science ®Google Scholar
• Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, Giles GG, Wallace AB, Anderson PR, Guiver TA, et al. 2013. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ. 346(1):f2360.
   PubMedGoogle Scholar
• Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, PRISMA-P Group. 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 4(1):1.
   PubMed Web of Science ®Google Scholar
• Muirhead CR, O'Hagan JA, Haylock RG, Phillipson MA, Willcock T, Berridge GL, Zhang W. 2009. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br J Cancer. 100(1):206–212.
   PubMed Web of Science ®Google Scholar
• NCRP. 2010. Potential Impact of Individual Genetic Susceptibility and Previous Radiation Exposure on Radiation Risk for Astronauts. Report No. 167. National Council on Radiation Protection & Measurement. 2010.
   Google Scholar
• Neriishi K, Nakashima E, Minamoto A, Fujiwara S, Akahoshi M, Mishima HK, Kitaoka T, Shore RE. 2007. Postoperative cataract cases among atomic bomb survivors: radiation dose response and threshold. Radiat Res. 168(4):404–408.
   PubMed Web of Science ®Google Scholar
• Niemierko A. 1997. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 24(1):103–110.
   PubMed Web of Science ®Google Scholar
• NRC. 1999. National Research Council, Committee on Health Risks of Exposure to Radon. Health effects of exposure to radon (BEIR VI). Washington, DC: National Academies Press.
   Google Scholar
• NRC. 2006. Health risks from exposures to low levels of ionizing radiation (BEIR VII), phase 2. Board on radiation effects research. Washington, DC: National Academies Press.
   Google Scholar
• Offit K, Thom P. 2007. Ethical and legal aspects of cancer genetic testing. Semin Oncol. 34(5):435–443.
   PubMed Web of Science ®Google Scholar
• Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, Howe NL, Ronckers CM, Rajaraman P, Craft AW, et al. 2012. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 380(9840):499–505.
   PubMed Web of Science ®Google Scholar
• Pedersen C, Pedersen C, Bräuner EV, Rod NH, Albieri V, Andersen CE, Ulbak K, Hertel O, Johansen C, Schüz J, et al. 2014. Distance to high-voltage power lines and risk of childhood leukemia–an analysis of confounding by and interaction with other potential risk factors. PloS One. 9(9):e107096.
   PubMed Web of Science ®Google Scholar
• Perko T, Van Oudheusden M, Turcanu C, Pölzl-Viol C, Oughton D, Schieber C, Schneider T, Zölzer F, Mays C, Martell M, et al. 2019. Towards a strategic research agenda for social sciences and humanities in radiological protection. J Radiol Prot. 39(3):766–784.
   PubMed Web of Science ®Google Scholar
• Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, Noguès C, Gauthier-Villars M, Lasset C, Fricker JP, Peock S, et al. 2012. GENEPSO; EMBRACE; HEBON. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). Bmj. 345(sep06 2):e5660.
   PubMedGoogle Scholar
• Porta M, editor. 2014. A Dictionary of Epidemiology. Oxford, UK: Oxford University Press
   Google Scholar
• Raemaekers JM, André MP, Federico M, Girinsky T, Oumedaly R, Brusamolino E, Brice P, Fermé C, van der Maazen R, Gotti M, et al. 2014. Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial. J Clin Oncol. 32(12):1188–1194.
   PubMed Web of Science ®Google Scholar
• Richardson DB, Cardis E, Daniels RD, Gillies M, O'Hagan JA, Hamra GB, Haylock R, Laurier D, Leuraud K, Moissonnier M, et al. 2015. Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (INWORKS). BMJ. 351:h5359.
   PubMed Web of Science ®Google Scholar
• Rosenberger A, Hung RJ, Christiani DC, Caporaso NE, Liu G, Bojesen SE, Le Marchand L, Haiman CA, Albanes D, Aldrich MC, et al. 2018. Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. Int Arch Occup Environ Health. 91(8):937–950.
   PubMed Web of Science ®Google Scholar
• Rosenstein BS, West CM, Bentzen SM, Alsner J, Andreassen CN, Azria D, Barnett GC, Baumann M, Burnet N, Chang-Claude J, Radiogenomics Consortium, et al. 2014. Radiogenomics: radiobiology enters the era of big data and team science. Int J Radiat Oncol Biol Phys. 89(4):709–713.
   PubMed Web of Science ®Google Scholar
• Rothman KJ, Greenland S, Lash TL. 2012. Modern epidemiology. Philadelphia, USA: Lippincott Wolters Kluwer.
   Google Scholar
• Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH. 1995. RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys. 31(5):1041–1042.
   PubMed Web of Science ®Google Scholar
• Rugbjerg K, Mellemkjaer L, Boice JD, Køber L, Ewertz M, Olsen JH. 2014. Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study. J Natl Cancer Inst. 106(6):dju110.
   PubMedGoogle Scholar
• Salerno S, Laghi A, Cantone MC, Sartori P, Pinto A, Frija G. 2019. Overdiagnosis and overimaging: an ethical issue for radiological protection. Radiol Med. 124(8):714–720.
   PubMed Web of Science ®Google Scholar
• Schofield PN, Kulka U, Tapio S, Grosche B. 2019. Big data in radiation biology and epidemiology; an overview of the historical and contemporary landscape of data and biomaterial archives. Int J Radiat Biol. 95(7):861–878.
   PubMed Web of Science ®Google Scholar
• Scholz-Kreisel P, Spix C, Blettner M, Eckerle S, Faber J, Wild P, Merzenich H, Hennewig U. 2017. Prevalence of cardiovascular late sequelae in long-term survivors of childhood cancer: a systematic review and meta-analysis. Pediatr Blood Cancer. 64(7):e26428.
   Web of Science ®Google Scholar
• Schonfeld SJ, Krestinina LY, Epifanova S, Degteva MO, Akleyev AV, Preston DL. 2013. Solid cancer mortality in the techa river cohort (1950–2007). Radiat Res. 179(2):183–189.
   PubMed Web of Science ®Google Scholar
• Schubauer-Berigan MK1, Daniels RD, Pinkerton LE. 2009. Radon exposure and mortality among white and American Indian uranium miners: an update of the Colorado Plateau cohort. Am J Epidemiol. 169(6):718–730.
   PubMed Web of Science ®Google Scholar
• Schwartz B, Benadjaoud MA, Cléro E, Haddy N, El-Fayech C, Guibout C, Teinturier C, Oberlin O, Veres C, Pacquement H, et al. 2014. Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment. Radiat Environ Biophys. 53(2):381–390.
   PubMed Web of Science ®Google Scholar
• Schwarz G, Dunning DE. Jr. 1982. Imprecision in estimates of dose from ingested 137Cs due to variability in human biological characteristics. Health Phys. 43(5):631–645.
   PubMed Web of Science ®Google Scholar
• Seegenschmiedt MH. 1998. Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives. Strahlenther Onkol. 174(3):25–29.
   PubMedGoogle Scholar
• Seibold P, Webb A, Aguado-Barrera ME, Azria D, Bourgier C, Brengues M, Briers E, Bultijnck R, Calvo-Crespo P, Carballo A, et al. 2019. REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer. Radioth Oncol. 138:59–67.
   PubMed Web of Science ®Google Scholar
• Sigurdson AJ, Bhatti P, Doody MM, Hauptmann M, Bowen L, Simon SL, Weinstock RM, Linet MS, Rosenstein M, Stovall M, et al. 2007. Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. Radiologic Technologists. Cancer Epidemiol Biomarkers Prev. 16(10):2000–2007.
   PubMed Web of Science ®Google Scholar
• Siiskonen T, Kaijaluoto S, Florea T. 2017. Imaging practices and radiation doses from imaging in radiotherapy. Phys Med. 42:247–252.
   PubMed Web of Science ®Google Scholar
• Storer JB, Fry RJ. 1995. On the shape of neutron dose-effect curves for radiogenic cancers and life shortening in mice. Radiat Environ Biophys. 34(1):21–27.
   PubMed Web of Science ®Google Scholar
• Suit H, Goldberg S, Niemierko A, Ancukiewicz M, Hall E, Goitein M, Wong W, Paganetti H. 2007. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res. 167(1):12–42.
   PubMed Web of Science ®Google Scholar
• Suslova KG, Sokolova AB, Krahenbuhl MP, Miller SC. 2009. The effects of smoking and lung health on the organ retention of different plutonium compounds in the Mayak PA workers. Radiat Res. 171(3):302–309.
   PubMed Web of Science ®Google Scholar
• Taylor AM, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA. 1975. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature. 258(5534):427–429.
   PubMed Web of Science ®Google Scholar
• Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, et al. 2017. Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer. JCO. 35(20):2288–2289.
   PubMed Web of Science ®Google Scholar
• Thomas J, Fermé C, Noordijk EM, Morschhauser F, Girinsky T, Gaillard I, Lugtenburg PJ, André M, Lybeert MLM, Stamatoullas A, et al. 2018. Comparison of 36 Gy, 20 Gy, or no radiation therapy after 6 cycles of EBVP chemotherapy and complete remission in early-stage Hodgkin lymphoma without risk factors: results of the EORT-GELA H9-F Intergroup Randomized Trial. Int J Radiat Oncol Biol Phys. 100(5):1133–1145.
   PubMed Web of Science ®Google Scholar
• Thome C, Chambers DB, Hooker AM, Thompson JW, Boreham DR. 2018. Deterministic effects to the lens of the eye following ionizing radiation exposure: is there evidence to support a reduction in threshold dose? Health Phys. 114(3):328–343.
   PubMed Web of Science ®Google Scholar
• Trotti A. 2002. The evolution and application of toxicity criteria. Semin Radiat Oncol. 12(1):1–3.
   PubMed Web of Science ®Google Scholar
• Tse LA, Yu IT, Qiu H, Au JS, Wang XR. 2011. A case-referent study of lung cancer and incense smoke, smoking, and residential radon in Chinese men. Environ Health Perspect. 119(11):1641–1646.
   PubMed Web of Science ®Google Scholar
• Tubiana M. 2009. Can we reduce the incidence of second primary maligancies occuring after radiotherapy? A critical review. Radiother Oncol. 91:4–15.
   PubMed Web of Science ®Google Scholar
• Turner MC, Krewski D, Chen Y, Pope CA, 3rd, Gapstur S, Thun MJ. 2011. Radon and lung cancer in the American Cancer Society cohort. Cancer Epidemiol Biomarkers Prev. 20(3):438–448.
   PubMed Web of Science ®Google Scholar
• Ulanowski A, Kaiser JC, Schneider U, Walsh L. 2019. On prognostic estimates of radiation risk in medicine and radiation protection. Radiat Environ Biophys. 58(3):305–319.
   PubMed Web of Science ®Google Scholar
• UNSCEAR 2012a. United Nations Scientific Committee on the Effects of Atomic Radiation 2012. Scientific Annex A: Attributing Health Effects to Ionizing Radiation Exposure and Inferring Risks, United Nations, 2012.
   Google Scholar
• UNSCEAR 2012b. United Nations Scientific Committee on the Effects of Atomic Radiation 2012. Scientific Annex B: Uncertainties in Risk Estimates for Radiation-induced Cancer, United Nations, 2012.
   Google Scholar
• UNSCEAR 2013. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, effects and risks of ionizing radiation. UNSCEAR 2013 report. Vol. II, Scientific Annex B, Effects of radiation exposure of children. New York, NY: United Nations.
   Google Scholar
• UNSCEAR 2017a. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, effects and risks of ionizing radiation. UNSCEAR 2017 report. Scientific Annexes A and B. New York, NY: United Nations.
   Google Scholar
• UNSCEAR 2017b. United Nations Scientific Committee on the Effects of Atomic Radiation 2017. Scientific Annex A: Principles and criteria for ensuring the quality of the Committee's reviews of epidemiological studies of radiation exposure, United Nations, 2017.
   Google Scholar
• UNSCEAR 2019. United Nations Scientific Committee on the Effects of Atomic Radiation 2019. Scientific Annex: Evaluations of Selected Health Effects and Inference of Risk Due to Radiation Exposure, United Nations, 2019.
   Google Scholar
• van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, et al. 2008. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 44(16):2418–2424.
   PubMed Web of Science ®Google Scholar
• van der Laan HP, van den Bergh A, Schilstra C, Vlasman R, Meertens H, Langendijk JA. 2008. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 70(4):1138–1145.
   PubMed Web of Science ®Google Scholar
• van Nimwegen FA, Ntentas G, Darby SC, Schaapveld M, Hauptmann M, Lugtenburg PJ, Janus CPM, Daniels L, van Leeuwen FE, Cutter DJ, et al. 2017. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood. 129(16):2257–2265.
   PubMed Web of Science ®Google Scholar
• Vienneau D, de Hoogh K, Hauri D, Vicedo-Cabrera AM, Schindler C, Huss A, Röösli M, SNC Study Group. 2017. Effects of radon and UV exposure on skin cancer mortality in Switzerland. Environ Health Perspect. 125(6):067009.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. 2014. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 12(12):1495–1499.
   PubMed Web of Science ®Google Scholar
• Wakeford R. 2012. Radiation effects: Modulating factors and risk assessment – an overview. Ann Icrp. 41(3–4):98–107.
   PubMedGoogle Scholar
• Wakeford R. 2013. The risk of childhood leukaemia following exposure to ionising radiation – a review. J Radiol Prot. 33(1):1–25.
   PubMed Web of Science ®Google Scholar
• Wakeford R, Tawn EJ. 2010. The meaning of low dose and low dose-rate. J Radiol Prot. 30(1):1–3.
   PubMed Web of Science ®Google Scholar
• Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. 2000. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 56(6):899–905.
   PubMed Web of Science ®Google Scholar
• West C, Azria D, Chang-Claude J, Davidson S, Lambin P, Rosenstein B, De Ruysscher D, Talbot C, Thierens H, Valdagni R, et al. 2014. The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors. Clin Oncol (R Coll Radiol). 26(12):739–742.
   PubMed Web of Science ®Google Scholar
• West C, Rosenstein BS, Alsner J, Azria D, Barnett G, Begg A, Bentzen S, Burnet N, Chang-Claude J, Chuang E, et al. 2010. Establishment of a Radiogenomics Consortium. Int J Radiat Oncol Biol Phys. 76(5):1295–1296.
   PubMed Web of Science ®Google Scholar
• Wild CP. 2005. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 14(8):1847–1850.
   PubMed Web of Science ®Google Scholar
• Winther JF, Kenborg L, Byrne J, Hjorth L, Kaatsch P, Kremer LC, Kuehni CE, Auquier P, Michel G, de Vathaire F, et al. 2015. Childhood cancer survivor cohorts in Europe. Acta Oncol. 54(5):655–668.
   PubMed Web of Science ®Google Scholar
• Wojcik A, Bouffler S, Hauptmann M, Rajaraman P. 2018. Considerations on the use of the terms radiosensitivity and radiosusceptibility. J Radiol Prot. 38(3):N25–N29.
   PubMed Web of Science ®Google Scholar
• Worgul BV, Kundiyev YI, Sergiyenko NM, Chumak VV, Vitte PM, Medvedovsky C, Bakhanova EV, Junk AK, Kyrychenko OY, Musijachenko NV, et al. 2007. Cataracts among Chernobyl clean-up workers: implications regarding permissible eye exposures. Radiat Res. 167(2):233–243.
   PubMed Web of Science ®Google Scholar
• Zhen Y, Jiang Y, Yuan L, Kirkpartrick J, Wu J, Ge Y. 2017. Analyzing the usage of standards in radiation therapy clinical studies. IEEE EMBS Int Conf Biomed Health Inform. 2017:349–352.
   PubMedGoogle Scholar
• Zvereva A, Kamp F, Schlattl H, Zankl M, Parodi K. 2018. Impact of interpatient variability on organ dose estimates according to MIRD schema: uncertainty and variance-based sensitivity analysis. Med Phys. 45(7):3391–3403.
   PubMed Web of Science ®Google Scholar